Full-Time

Manufacturing Operations Manager

Tablet manufacturing

Nivagen Pharmaceuticals

Nivagen Pharmaceuticals

51-200 employees

Develops, acquires, and markets generic drugs

No salary listed

Pittsburg, CA, USA

In Person

Bachelor's

Category
Operations & Logistics (1)
Required Skills
Inventory Management

Get referred to Nivagen Pharmaceuticals

See people who can refer or advise you

Requirements
  • A Bachelor’s degree with 5 to 10 years of experience in a pharmaceutical, nutraceutical, or supplement environment.
  • Five to 10 years of experience in pharmaceutical production.
  • In-depth knowledge of current Good Manufacturing Practice regulatory requirements related to pharmaceutical production.
  • Ability to operate pharmaceutical manufacturing machinery.
  • Solid mechanical aptitude and troubleshooting skills.
  • Ability to execute manufacturing procedures in accordance with batch manufacturing records, Standard Operating Procedures, and Good Manufacturing Practice requirements.
  • Excellent written and verbal communication skills.
  • Excellent math skills.
  • Ability to read and comprehend Standard Operating Procedures, batch records, and training documents.
  • Ability to multitask effectively.
  • Ability to interact effectively with different functional groups.
Responsibilities
  • Operate production equipment, including blenders, tablet presses, high-shear granulators, tray dryers, fluid-bed processing units, mixers, pumps, vacuum and loading machines, labeling and imprinting machines, sealers, bottle-filling machines, cappers, and induction sealers, in a current Good Manufacturing Practice facility.
  • Draft and manage daily and weekly production schedules.
  • Ensure compliance with Good Manufacturing Practice, Occupational Safety and Health Administration, and Environmental Health and Safety requirements, and implement necessary regulatory changes.
  • Manage the workload of technicians and support staff across mixing, granulation, drying, blending, compression, coating, packaging, receiving, and warehouse functions.
  • Coordinate with relevant functional groups to meet production protocols and target volumes.
  • Collaborate with research and development, engineering, and quality control teams to support product launches, process validations, and technology transfers.
  • Troubleshoot and investigate deviations, participate in process optimization, support quality assurance and other functions during internal and external audits, including Food and Drug Administration audits, and support change control.
  • Draft Standard Operating Procedures, training manuals, qualification documents, protocols, and other controlled documents.
  • Manage receiving and warehouse personnel, inventory, and supply ordering.
  • Perform duties in compliance with current Good Manufacturing Practices, the company Quality Manual, and facility Standard Operating Procedures.
  • Record operations in packaging records, logbooks, and controlled documents.
  • Assemble, disassemble, operate, and clean production equipment.
  • Assist with routine preventive maintenance of utilities, production equipment, and packaging equipment.
  • Clean and maintain production environments.
  • Perform line clearances before production orders to remove materials and documents from previous orders.
  • Promote continuous improvement by encouraging team suggestions, implementing best practices, and monitoring key performance indicators to drive operational excellence.
Nivagen Pharmaceuticals

Nivagen Pharmaceuticals

View

Nivagen Pharmaceuticals develops, acquires, and sells generic prescription drugs and OTC products for the North American market. It leverages global partnerships with FDA-approved manufacturing facilities to deliver high-quality, affordable products and collaborates with the world’s best CROs and CRAMs to develop and manufacture niche generics. The company supports small FDA-qualified manufacturers entering the U.S. market and differentiates itself through its ability to launch new generic products and its strong sales and marketing team, rather than relying on a single manufacturing or development approach. Revenue comes from product development, co-development, acquisitions, in-licensing, and providing sales and marketing services. Nivagen aims to grow its portfolio by forging CRO/CRAM partnerships, acquiring existing products, and expanding its product lineup to capture a larger share of the evolving generic and OTC market in North America.

Company Size

51-200

Company Stage

Growth Equity (Venture Capital)

Total Funding

$26M

Headquarters

Sacramento, California

Founded

2009

Get referred to Nivagen Pharmaceuticals

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • PAI Pharma's January 6, 2026 acquisition brings Olympus-backed capital and distribution.
  • Owning the Sacramento site after February 2026 strengthens expansion and regulatory control.
  • Shortage-sensitive injectable demand supports faster commercialization for Nivagen's RTU pipeline.

What critics are saying

  • Nivagen's zinc oxide Class II recall, started October 31, 2025, remains ongoing.
  • California recalled atorvastatin tablets in September 2024 for a carbamazepine mix-up.
  • Repeated cGMP failures or sterile contamination would trigger FDA shutdowns and destroy hospital trust.

What makes Nivagen Pharmaceuticals unique

  • Sacramento's 100,000-square-foot sterile facility makes Nivagen unusually domestic for injectables.
  • Nivagen built over 20 ready-to-use sterile injectables before PAI Pharma's January 2026 acquisition.
  • Its 503B compounding and CDMO services target shortage-driven hospital demand directly.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Paid Time Off

401 (k) savings plan

Growth & Insights and Company News

Headcount

6 month growth

-4%

1 year growth

-4%

2 year growth

-7%
PE Hub
Jan 6th, 2026
Olympus-backed PAI Pharma picks up Nivagen Pharmaceuticals

Olympus-backed PAI Pharma picks up Nivagen Pharmaceuticals. Headquartered in Greenville, South Carolina, PAI is a developer, manufacturer and marketer of oral liquid medicines. * Nivagen operates an aseptic manufacturing facility in Sacramento, California, designed to support the production of IV bags, vials, prefilled syringes, and cartridges * Nivagen was founded in 2009 PAI Pharma, which is backed by Olympus Partners, has acquired Nivagen Pharmaceuticals, Inc, a Sacramento, California-based pharmaceutical company. No financial terms were disclosed. Gain instant access to our expert editorial analysis and in-depth insight. Already have an account? Sign in.

Benzinga
Jan 6th, 2026
PAI Pharma acquires Nivagen to expand US sterile injectable manufacturing amid persistent drug shortages

PAI Pharma, a portfolio company of Olympus Partners, has acquired Nivagen Pharmaceuticals, a California-based pharmaceutical company specialising in ready-to-use sterile injectables. The deal expands PAI's domestic manufacturing capabilities and addresses persistent drug shortages in the US healthcare system. Nivagen operates a state-of-the-art aseptic manufacturing facility in Sacramento, producing IV bags, vials, prefilled syringes and cartridges. The company brings over 20 injectable products to complement PAI's existing sterile portfolio of approximately 10 products in development and four on the market. The acquisition aligns with growing efforts to reshore pharmaceutical production and reduce reliance on foreign supply chains. PAI Pharma was advised by Bourne Partners, Kirkland & Ellis and KPMG, whilst Olympus Partners provided backing for the transaction.

Private Equity Info
Aug 22nd, 2022
Corbel Capital Partners invests into Nivagen Pharmaceuticals, Inc.

Corbel Capital Partners invested in Nivagen Pharmaceuticals (Sacramento, CA, US), a specialty pharmaceuticals business that develops and sells generic and branded prescription drugs.